BullFrog AI Holdings, Inc.’s SEC filings document a Nasdaq-listed AI drug discovery company with common stock and tradable warrants on the Nasdaq Capital Market. Recent Current Reports describe material events including Nasdaq continued-listing matters, stockholders’ equity and minimum bid-price compliance, sales under at-the-market and equity-line facilities, and shareholder communications about commercial execution.
The company’s filings also record a feasibility agreement applying bfLEAP® to major depressive disorder drug-target discovery, including milestone-payment and intellectual-property provisions. Proxy materials disclose annual meeting procedures, voting eligibility, director-nomination deadlines, shareholder proposal rules, board matters and other governance items for BullFrog AI stockholders.
BullFrog AI Holdings, Inc. (BFRG) reported that its Chief Financial Officer, Joshua Blacher, purchased 50,000 shares of common stock on September 22, 2026. The shares were bought in open market or private transactions at a weighted average price of $0.5285 per share, with individual trade prices ranging from $0.52 to $0.5294. Following this purchase, he directly owns 65,000 common shares, and no Rule 10b5-1 trading plan is reported.
BullFrog AI Holdings, Inc. (BFRG) disclosed that Chief Executive Officer, director, and ten percent owner Vininder Singh purchased 75,000 shares of common stock on September 22, 2026 in an open-market or private transaction at a weighted average price of $0.5989 per share, with individual trade prices ranging from $0.5169 to $0.65 per share.
Following this purchase, Singh directly owns 2,442,446 common shares. The filing indicates these transactions were not made under a Rule 10b5-1 trading plan.
BullFrog AI Holdings, Inc. (BFRG) reports that Nasdaq has granted an additional 180-day period, until February 8, 2027, for the company to regain compliance with the Nasdaq Minimum Bid Price Requirement of $1.00 per share. The company previously failed to meet this standard for 30 consecutive business days and had an initial compliance period through August 10, 2026. BullFrog AI has informed Nasdaq that, if the deficiency is not cured through market trading, it intends to use an already approved reverse stock split, at a ratio between 1‑for‑2 and 1‑for‑15, at the board’s discretion. If the company does not regain compliance by the end of the Second Compliance Period, its securities will be subject to delisting, though it would have the right to appeal to a Nasdaq Hearings Panel.
BullFrog AI Holdings, Inc. reported minimal early-stage revenue and continuing losses for the six months ended June 30, 2026 while raising significant equity to extend its runway. Collaboration revenue was $215,385, all from a new feasibility agreement with a global pharmaceutical company, producing gross profit of $106,899.
Operating expenses were $3.1 million, mainly research and development of $774,275 and general and administrative costs of $2.37 million, leading to a net loss of $2,964,691. Operating cash use was $3.21 million. The company offset this through financings, receiving $7.85 million net from common stock sales under its at-the-market program and equity line, ending with cash and restricted cash of about $7.0 million and stockholders’ equity of $6,987,262.
Management states this cash is not sufficient to fund planned operations for 12 months, and the filing notes substantial doubt about the ability to continue as a going concern. BullFrog AI also discloses noncompliance with Nasdaq’s $1.00 minimum bid-price requirement and a one-year panel monitoring period following recent stockholders’ equity noncompliance, with potential reverse stock split authority already approved.
BullFrog AI Holdings, Inc. filed a prospectus to register for resale up to 2,000,000 shares of its common stock by Lincoln Park Capital Fund, LLC. These are resale shares; the company will not receive proceeds from Lincoln Park’s secondary sales, though it may receive up to $4,099,102 in gross proceeds if it elects to sell additional shares to Lincoln Park under the Purchase Agreement.
The prospectus states 18,541,651 shares outstanding as of May 13, 2026 (16,140,938 held by non-affiliates) and estimates 20,541,651 shares outstanding if the full 2,000,000 registered shares are issued. The Purchase Agreement caps Lincoln Park’s beneficial ownership at 4.99%. The filing also discloses Nasdaq compliance activity, an auditor going-concern explanatory paragraph, and a last reported sale price of $0.72 on May 28, 2026.
BullFrog AI Holdings, Inc. increased Chief Executive Officer Vininder Singh’s annual base salary from $400,000 to $600,000, effective June 11, 2026, and set his target annual bonus at up to 50% of base salary. The Compensation Committee cited competitive market data and Mr. Singh’s contributions to the company’s strategic and operational objectives.
On the same date, BullFrog AI held its 2026 Annual Meeting of Stockholders, with 7,794,169 shares present or represented by proxy, representing approximately 42.06% of shares entitled to vote. Stockholders elected four directors—William Enright, Jason D. Hanson, R. Donald Elsey, and Vininder Singh—and ratified the appointment of M&K CPAs, PLLC as independent registered public accounting firm for the fiscal year ending December 31, 2026.
BullFrog AI Holdings director Jason David Hanson received a grant of stock options as compensation. He was awarded 15,000 options to buy BullFrog AI common stock at an exercise price of $0.6281 per share, bringing his reported option holdings to 15,000 options.
The options were granted under the company’s 2022 Equity Compensation Plan and vest on June 11, 2027, with forfeiture restrictions accelerating upon a change in control of the company or a significant financing as defined in the plan. The options expire on June 12, 2036. This is a grant/award transaction, not an open-market purchase or sale.
BullFrog AI Holdings director William Enright received a compensation grant of stock options covering 15,000 shares of common stock. The options have an exercise price of $0.6281 per share, were granted at market price on the grant date, and vest on June 11, 2027. They were issued under the company’s 2022 Equity Compensation Plan and expire on June 12, 2036, with vesting able to accelerate upon a change in control or a significant financing as defined in the plan.
BullFrog AI Holdings director Elsey R Don received a stock option grant as equity compensation. The grant covers 15,000 stock options for common stock at an exercise price of $0.6281 per share. These options vest on June 11, 2027 and were issued under the company’s 2022 Equity Compensation Plan. The options expire on June 12, 2036 and were granted based on the market price on the grant date.